Back | Next |
home / stock / sgmo / sgmo message board
Subject | By | Source | When |
---|---|---|---|
HC Wainright tags $SGMO at 25.00. My guess | Seeker213 | investorshub | 12/26/2020 11:53:52 PM |
No, I think it plays catchup to the | MWM | investorshub | 12/24/2020 3:51:21 PM |
I think later next year if we see | The Canes | investorshub | 12/24/2020 3:35:46 PM |
$SGMO I have a good feeling about this one. | MWM | investorshub | 12/24/2020 11:14:27 AM |
SGMO Sangamo has prioritized intellectual property as an | MWM | investorshub | 12/24/2020 1:32:57 AM |
Got some Jan $20 calls $SGMO$ | Rockurstocks | investorshub | 12/23/2020 6:22:05 PM |
$SGMO I reloaded on the dip today, looks | MWM | investorshub | 12/23/2020 5:57:25 PM |
A double from here looks very doable comparing | MWM | investorshub | 12/23/2020 12:02:53 PM |
$SGMO moving toward stratosphere, finally...50-100. | hitekmastr | investorshub | 12/23/2020 11:50:58 AM |
What a beast!!! | Fress | investorshub | 12/22/2020 8:05:09 PM |
$SGMO added some calls, I think Sangamo is | MWM | investorshub | 12/22/2020 5:24:19 PM |
$SGMO staying, forming a nice chart towards 25 | Seeker213 | investorshub | 12/22/2020 1:59:44 PM |
$SGMO ready for next leg up 20-25. Going long | Seeker213 | investorshub | 12/22/2020 11:30:19 AM |
$20.00 soon hasn't run like Beam or Edit | Fress | investorshub | 12/22/2020 10:39:31 AM |
Strong close yesterday. Someone acquiring 100k, 200k towards close | Seeker213 | investorshub | 12/19/2020 11:40:54 AM |
https://www.bizjournals.com/sanfrancisco/blog/biotech/2015/03/hiv-aids-cirm-stem | Seeker213 | investorshub | 12/12/2020 1:42:44 PM |
What happened to the hiv drug they had | akamaii | investorshub | 12/12/2020 1:39:08 PM |
$SGMO Huge pipeline too cheap here. Another CSPR | Seeker213 | investorshub | 12/11/2020 7:11:30 PM |
HEARING $SGMO $CEO just said | MWM | investorshub | 12/11/2020 5:26:44 PM |
Sangamo participates in a conference call with Truist | MWM | investorshub | 12/11/2020 11:04:00 AM |
News, Short Squeeze, Breakout and More Instantly...
Sangamo Therapeutics Inc. Company Name:
SGMO Stock Symbol:
NASDAQ Market:
2024-05-15 13:30:05 ET H.C. Wainwright analyst issues UNDERPERFORM recommendation for SGMO on May 15, 2024 11:01AM ET. The previous analyst recommendation was Underperform. SGMO was trading at $0.5901 at issue of the analyst recommendation. The overall analyst consensus ...
Showcased 20 presentations at the 27 th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting demonstrating progression of neurology-focused preclinical pipeline, including additional data from novel delivery capsid, STAC-BBB, that demonstrated industry-leading blood-brain barrie...
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today presented pre-clinical data showcasing its novel next-generation integrase technology engineered to enable large-scale genome editing. Building on Sangamo’s deep expertise in protein-DNA interactions derived from...